Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance

OBJECTIVE: Lack of effective therapies remains a problem in the treatment of oral squamous cell carcinoma (OSCC), especially in patients with advanced tumors. OSCC development is driven by multiple aberrancies within the cell cycle pathway, including amplification of cyclin D1 and loss of p16. Hence...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Biol Med
Main Authors: Zainal, Nur Syafinaz, Lee, Bernard Kok Bang, Wong, Zheng Wei, Chin, Iuan Sheau, Yee, Pei San, Gan, Chai Phei, Mun, Kein Seong, Rahman, Zainal Ariff Abdul, Gutkind, J. Silvio, Patel, Vyomesh, Cheong, Sok Ching
Format: Artigo
Jezik:Inglês
Izdano: Chinese Anti-Cancer Association 2019
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6713638/
https://ncbi.nlm.nih.gov/pubmed/31516747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2018.0257
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki